Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Imaging-assisted nanoimmunotherapy for atherosclerosis in multiple species

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Delivery mode and gut microbial changes correlate with an increased risk of childhood asthma

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Epigenetic markers associated with metformin response and intolerance in drug-naive patients with type 2 diabetes

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Distinct immune phenotypes in infants developing asthma during childhood

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. A dual-action peptide-containing hydrogel targets wound infection and inflammation

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Filamentous bacteriophages are associated with chronic Pseudomonas lung infections and antibiotic resistance in cystic fibrosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Effect of liraglutide on expression of inflammatory genes in type 2 diabetes

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Ceramides and phospholipids are downregulated with liraglutide treatment: results from the LiraFlame randomized controlled trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Effect of Liraglutide on Vascular Inflammation Evaluated by [64Cu]DOTATATE

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Effects of Empagliflozin on Myocardial Flow Reserve in Patients With Type 2 Diabetes Mellitus: The SIMPLE Trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Tina Binderup
  • Raphaël Duivenvoorden
  • Francois Fay
  • Mandy M T van Leent
  • Joost Malkus
  • Samantha Baxter
  • Seigo Ishino
  • Yiming Zhao
  • Brenda Sanchez-Gaytan
  • Abraham J P Teunissen
  • Yohana C A Frederico
  • Jun Tang
  • Giuseppe Carlucci
  • Serge Lyashchenko
  • Claudia Calcagno
  • Nicolas Karakatsanis
  • Georgios Soultanidis
  • Max L Senders
  • Philip M Robson
  • Venkatesh Mani
  • Sarayu Ramachandran
  • Mark E Lobatto
  • Barbara A Hutten
  • Juan F Granada
  • Thomas Reiner
  • Filip K Swirski
  • Matthias Nahrendorf
  • Andreas Kjaer
  • Edward A Fisher
  • Zahi A Fayad
  • Carlos Pérez-Medina
  • Willem J M Mulder
View graph of relations

Nanomedicine research produces hundreds of studies every year, yet very few formulations have been approved for clinical use. This is due in part to a reliance on murine studies, which have limited value in accurately predicting translational efficacy in larger animal models and humans. Here, we report the scale-up of a nanoimmunotherapy from mouse to large rabbit and porcine atherosclerosis models, with an emphasis on the solutions we implemented to overcome production and evaluation challenges. Specifically, we integrated translational imaging readouts within our workflow to both analyze the nanoimmunotherapeutic's in vivo behavior and assess treatment response in larger animals. We observed our nanoimmunotherapeutic's anti-inflammatory efficacy in mice, as well as rabbits and pigs. Nanoimmunotherapy-mediated reduction of inflammation in the large animal models halted plaque progression, supporting the approach's translatability and potential to acutely treat atherosclerosis.

Original languageEnglish
JournalScience translational medicine
Volume11
Issue number506
ISSN1946-6234
DOIs
Publication statusPublished - 21 Aug 2019

ID: 59319611